DK0803249T3 - Cholesterolsænkende drikkeblandingssammensætninger - Google Patents

Cholesterolsænkende drikkeblandingssammensætninger

Info

Publication number
DK0803249T3
DK0803249T3 DK97302357T DK97302357T DK0803249T3 DK 0803249 T3 DK0803249 T3 DK 0803249T3 DK 97302357 T DK97302357 T DK 97302357T DK 97302357 T DK97302357 T DK 97302357T DK 0803249 T3 DK0803249 T3 DK 0803249T3
Authority
DK
Denmark
Prior art keywords
drink mix
cholesterol lowering
mix compositions
compositions
lowering drink
Prior art date
Application number
DK97302357T
Other languages
Danish (da)
English (en)
Inventor
Sherry Lynn Diehl
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of DK0803249T3 publication Critical patent/DK0803249T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/25Synthetic polymers, e.g. vinylic or acrylic polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK97302357T 1996-04-26 1997-04-07 Cholesterolsænkende drikkeblandingssammensætninger DK0803249T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/638,246 US5942550A (en) 1996-01-25 1996-04-26 Cholesterol lowering drink mix compositions

Publications (1)

Publication Number Publication Date
DK0803249T3 true DK0803249T3 (da) 2003-01-06

Family

ID=24559232

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97302357T DK0803249T3 (da) 1996-04-26 1997-04-07 Cholesterolsænkende drikkeblandingssammensætninger

Country Status (7)

Country Link
US (1) US5942550A (de)
EP (1) EP0803249B1 (de)
AT (1) ATE229321T1 (de)
DE (1) DE69717706T2 (de)
DK (1) DK0803249T3 (de)
ES (1) ES2184031T3 (de)
PT (1) PT803249E (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030091716A1 (en) * 2001-11-09 2003-05-15 Simpey Kuramoto Stable homogeneous drink composition including particulate cereal product
JP3930897B1 (ja) * 2006-08-16 2007-06-13 太陽化学株式会社 粘度発現性を改良した増粘用組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1181003A (en) * 1967-03-20 1970-02-11 Mead Johnson & Co Therapeutic Compositions
US3974272A (en) * 1972-09-01 1976-08-10 Merck & Co., Inc. Palatable cholestyramine coacervate compositions
US4548806A (en) * 1982-07-23 1985-10-22 G. D. Searle & Co. Psyllium hydrophilic mucilloid composition
US4459280A (en) * 1982-07-23 1984-07-10 G. D. Searle & Co. Psyllium hydrophilic mucilloid composition
US4722847A (en) * 1986-05-07 1988-02-02 The Procter & Gamble Company Fruit juice beverages and juice concentrates nutritionally supplemented with calcium
US4895723A (en) * 1986-09-08 1990-01-23 Amer And Company Cholestyramine compositions and method for preparation thereof
CA1313135C (en) * 1987-02-09 1993-01-26 The Dow Chemical Company Cholestyramine composition and process for its preparation
DE320519T1 (de) * 1987-12-14 1989-10-26 The Boeing Co., Seattle, Wash. Cholestyraminzusammensetzungen und verfahren zu ihrer herstellung.
US5186965A (en) * 1990-06-14 1993-02-16 The Procter & Gamble Company Calcium citrate malate composition
US5380522A (en) * 1992-08-11 1995-01-10 Day; Charles E. Method for treatment of irritable bowel syndrome
US5422101A (en) * 1993-05-14 1995-06-06 The Procter & Gamble Company Cholesterol lowering drink mix compositions
US5612026A (en) * 1996-01-25 1997-03-18 The Procter & Gamble Company Cholesterol lowering drink mix compositons

Also Published As

Publication number Publication date
PT803249E (pt) 2003-04-30
EP0803249A3 (de) 1999-01-07
DE69717706D1 (de) 2003-01-23
US5942550A (en) 1999-08-24
EP0803249A2 (de) 1997-10-29
ES2184031T3 (es) 2003-04-01
ATE229321T1 (de) 2002-12-15
DE69717706T2 (de) 2003-09-18
EP0803249B1 (de) 2002-12-11

Similar Documents

Publication Publication Date Title
MY109880A (en) Substituted biphenylpyridones
DE69111480D1 (de) Gefüllter und abgedichteter, unabhängiger Mischbehälter.
GR3036622T3 (en) Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds
SI0725779T1 (de)
AU1808595A (en) 3,8-diazabicyclo{3.2.1}octane derivatives having analgesic activity
TW260704B (de)
ZA933273B (en) Sulfonylbenzyl-substituted benzo- and pyridopyridones
HUT76428A (en) Granular formulation containing microorganisms, and process for the preparation
EP0643038A3 (de) Polyfunktionelle kationische Tenside, deren Zusammensetzungen, Verfahren zu deren Herstellung und Verwendungen.
ITRM910151A0 (it) Perfezionamento nei containers, cassoni e simili auto-sollevabili e mobilizzabili manualmente.
DK0803249T3 (da) Cholesterolsænkende drikkeblandingssammensætninger
BR9802803A (pt) ação e composições farmacêuticas contendo os mesmos.
GB9425735D0 (en) Pillar bipolar transistors
IL108997A0 (en) Heterotricyclically substituted phenyl-cyclohexane-carboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
MY108877A (en) Substituted quinol-2-yl-methoxy-phenylacetic acid derivatives.
TW276269B (de)
MX9201827A (es) Composicion suavizadora liquida.
HUT70614A (en) 3,4-dioxo-1-cyclobuten-1-yl-substituted (indolyl-alkyl)-pyridine- and -pyrimidine derivatives and antimigraine compositions containing them as active component
GB2284589B (en) Improvements in and relating to packaged fermented products, such as beer and the like
FI944162A0 (fi) Maustamattomia ratamojuomaseoskoostumuksia
EP0190860A3 (de) 6-Chloro-3-methyl-1H-2,3,4,5-tetrahydro-3-benzazepin-N-oxyd und dieses enthaltende Arzneimittel
DE69738917D1 (de) Flüssigkristallzusammensetzung, deren Herstellung und damit erzeugtes Flüssigkristallelement
AU4974493A (en) Dermatitis treatment compositions containing sulphur, salicylic acid and dimethylsulphone
DE3581641D1 (de) 1,4-thiazinabkoemmlinge, deren herstellung und diese enthaltende kardiotonische mittel.
ATE95546T1 (de) Polymerische zusammensetzungen und ihre anwendung fuer behaelterverschluesse.